Notch2 Pathway Mediates Breast Cancer Cellular Dormancy and Mobilisation in Bone and Contributes to Haematopoietic Stem Cell Mimicry

Overview

Journal Br J Cancer

Specialty Oncology

Date 2019 Jun 27

PMID 31239543

Citations 41

Authors

Mattia Capulli

Dayana Hristova

Zoe Valbret

Kashmala Carys

Ronak Arjan

Antonio Maurizi

Francesco Masedu

Alfredo Cappariello

Nadia Rucci

Anna Teti

Affiliations

Soon will be listed here.

Abstract

Background: Recurrence after >5-year disease-free survival affects one-fifth of breast cancer patients and is the clinical manifestation of cancer cell reactivation after persistent dormancy.

Methods: We investigated cellular dormancy in vitro and in vivo using breast cancer cell lines and cell and molecular biology techniques.

Results: We demonstrated cellular dormancy in breast cancer bone metastasis, associated with haematopoietic stem cell (HSC) mimicry, in vivo competition for HSC engraftment and non-random distribution of dormant cells at the endosteal niche. Notch2 signal implication was demonstrated by immunophenotyping the endosteal niche-associated cancer cells and upon co-culture with sorted endosteal niche cells, which inhibited breast cancer cell proliferation in a Notch2-dependent manner. Blocking this signal by in vivo acute administration of the γ-secretase inhibitor, dibenzazepine, induced dormant cell mobilisation from the endosteal niche and colonisation of visceral organs. Sorted Notch2 breast cancer cells exhibited a unique stem phenotype similar to HSCs and in vitro tumour-initiating ability in mammosphere assay. Human samples confirmed the existence of a small Notch2 cell population in primary and bone metastatic breast cancers, with a survival advantage for Notch2 vs Notch2 patients.

Conclusions: Notch2 represents a key determinant of breast cancer cellular dormancy and mobilisation in the bone microenvironment.

Citing Articles

Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.

Correlation of GD2 Biosynthesis Enzymes With Cancer Stem Cell Markers in Human Breast Cancer.

ONeill N, Rizk M, Li A, Martin T, Jiang W, Mokbel K Cancer Genomics Proteomics. 2025; 22(2):231-246.

PMID: 39993803 PMC: 11880921. DOI: 10.21873/cgp.20498.

Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.

Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K Mol Cancer. 2025; 24(1):47.

PMID: 39953555 PMC: 11829473. DOI: 10.1186/s12943-025-02250-9.

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Tufail M, Jiang C, Li N Mil Med Res. 2025; 12(1):7.

PMID: 39934876 PMC: 11812268. DOI: 10.1186/s40779-025-00595-2.

Standardization of a Model of Vertebral Metastasis of Breast Cancer in CD1/Nu/Nu Mice.

Reyes Soto G, Miranda-Galvan V, Uribe-Uribe N, Escobar-Valderrama J, Alanis-Mendizabal J, Medina-Velazquez L Cureus. 2025; 17(1):e77291.

PMID: 39931605 PMC: 11809943. DOI: 10.7759/cureus.77291.

References

Wright L, Ottewell P, Rucci N, Peyruchaud O, Pagnotti G, Chiechi A . Murine models of breast cancer bone metastasis. Bonekey Rep. 2016; 5:804. PMC: 5108088. DOI: 10.1038/bonekey.2016.31. View

Naumov G, Townson J, MacDonald I, Wilson S, Bramwell V, Groom A . Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 2004; 82(3):199-206. DOI: 10.1023/B:BREA.0000004377.12288.3c. View

Gyorffy B, Lanczky A, Eklund A, Denkert C, Budczies J, Li Q . An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2009; 123(3):725-31. DOI: 10.1007/s10549-009-0674-9. View

Shiozawa Y, Berry J, Eber M, Jung Y, Yumoto K, Cackowski F . The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer. Oncotarget. 2016; 7(27):41217-41232. PMC: 5173053. DOI: 10.18632/oncotarget.9251. View

Visnjic D, Kalajzic Z, Rowe D, Katavic V, Lorenzo J, Aguila H . Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood. 2004; 103(9):3258-64. DOI: 10.1182/blood-2003-11-4011. View

Paez D, LaBonte M, Bohanes P, Zhang W, Benhanim L, Ning Y . Cancer dormancy: a model of early dissemination and late cancer recurrence. Clin Cancer Res. 2011; 18(3):645-53. DOI: 10.1158/1078-0432.CCR-11-2186. View

Bromberg O, Frisch B, Weber J, Porter R, Civitelli R, Calvi L . Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood. 2012; 120(2):303-13. PMC: 3398755. DOI: 10.1182/blood-2011-09-377853. View

Boyerinas B, Zafrir M, Yesilkanal A, Price T, Hyjek E, Sipkins D . Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood. 2013; 121(24):4821-31. PMC: 3682335. DOI: 10.1182/blood-2012-12-475483. View

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

10.

Lynch C . Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. Bone. 2010; 48(1):44-53. DOI: 10.1016/j.bone.2010.06.007. View

11.

Abravanel D, Belka G, Pan T, Pant D, Collins M, Sterner C . Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. J Clin Invest. 2015; 125(6):2484-96. PMC: 4497740. DOI: 10.1172/JCI74883. View

12.

Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

13.

Nie Y, Han Y, Zou Y . CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med. 2008; 205(4):777-83. PMC: 2292218. DOI: 10.1084/jem.20072513. View

14.

Klevesath M, Pantel K, Agbaje O, Provenzano E, Wishart G, Gough P . Patterns of metastatic spread in early breast cancer. Breast. 2013; 22(4):449-54. DOI: 10.1016/j.breast.2013.04.017. View

15.

Wang J, Wakeman T, Lathia J, Hjelmeland A, Wang X, White R . Notch promotes radioresistance of glioma stem cells. Stem Cells. 2009; 28(1):17-28. PMC: 2825687. DOI: 10.1002/stem.261. View

16.

Yin T, Li L . The stem cell niches in bone. J Clin Invest. 2006; 116(5):1195-201. PMC: 1451221. DOI: 10.1172/JCI28568. View

17.

Roodman G . Mechanisms of bone metastasis. N Engl J Med. 2004; 350(16):1655-64. DOI: 10.1056/NEJMra030831. View

18.

ONeill C, Urs S, Cinelli C, Lincoln A, Nadeau R, Leon R . Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol. 2007; 171(3):1023-36. PMC: 1959488. DOI: 10.2353/ajpath.2007.061029. View

19.

Orford K, Scadden D . Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat Rev Genet. 2008; 9(2):115-28. DOI: 10.1038/nrg2269. View

20.

Johnson R, Finger E, Olcina M, Vilalta M, Aguilera T, Miao Y . Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016; 18(10):1078-1089. PMC: 5357601. DOI: 10.1038/ncb3408. View